Sound Income Strategies LLC Raises Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Sound Income Strategies LLC boosted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.8% during the fourth quarter, HoldingsChannel reports. The firm owned 507,213 shares of the pharmacy operator’s stock after buying an additional 23,373 shares during the period. Sound Income Strategies LLC’s holdings in Walgreens Boots Alliance were worth $4,732,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. First Financial Corp IN raised its holdings in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares in the last quarter. TD Private Client Wealth LLC grew its position in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 3,208 shares during the last quarter. Sentry Investment Management LLC purchased a new position in Walgreens Boots Alliance in the 3rd quarter worth $30,000. Eastern Bank bought a new stake in Walgreens Boots Alliance in the third quarter worth $33,000. Finally, Strategic Investment Solutions Inc. IL purchased a new stake in Walgreens Boots Alliance during the second quarter valued at about $34,000. 58.59% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

WBA has been the subject of a number of recent research reports. Jefferies Financial Group lowered their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Barclays boosted their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. TD Cowen decreased their target price on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Bank of America increased their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Finally, Truist Financial boosted their price objective on shares of Walgreens Boots Alliance from $10.00 to $13.00 and gave the company a “hold” rating in a research report on Thursday, January 16th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $13.27.

Walgreens Boots Alliance Stock Up 1.0 %

NASDAQ WBA opened at $11.74 on Friday. The stock’s 50 day moving average is $9.73 and its 200 day moving average is $9.86. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $23.76.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the prior year, the firm earned $0.66 EPS. The company’s revenue was up 7.6% compared to the same quarter last year. On average, equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.59 earnings per share for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.